Common use of Smoking During Pregnancy Clause in Contracts

Smoking During Pregnancy. At any time (%): Equity  Aboriginal women Decrease from previous year Increase on previous year No change Decrease from previous year Equity  Non-aboriginal women Decrease from previous year Increase on previous year No change Decrease from previous year Effectiveness Pregnant Women Quitting Smoking - By second half of pregnancy (%) 4% increase on previous year <1% increase on previous year ≥1% and <4% increase on previous year 4% increase on previous year 1.4 Population Health Human Immunodeficiency Virus (HIV) Testing - Within publicly-funded HIV and sexual health services: Variance (%) Individual - See Data Supplement <98 Target >=98 and <100 >=100 Effectiveness Hepatitis C Antiviral Treatment Initiation – Direct acting - by LHD residents: Variance (%) Individual - See Data Supplement <98 Target >=98 and <100 >=100 Strategy 2: Provide World-Class Clinical Care Where Patient Safety is First 2.1 Safety Fall-related Injuries in Hospital – Resulting in fracture or intracranial injury – Rate (per 1,000 bed days) <0.12 >=0.15 >=0.12 and <0.15 <0.12 Safety 3rd or 4th Degree Perineal Lacerations During Delivery (Rate per 1,000 bed days) <0.28 >=0.39 >=0.28 and <0.39 <0.28 Safety Hospital Acquired Venous Thromboembolism (Rate per 1,000 bed days) <0.21 >=0.30 >=0.21 and <0.30 <0.21 Safety Hospital Acquired Pressure Injuries (Rate per 1,000 bed days) <0.27 >=0.44 >=0.27 and <0.44 <0.27 Safety Healthcare Associated Infections (per 1,000 bed days) <2.64 >=2.99 >=2.64 and <2.99 <2.64 Safety Surgical Complications Requiring Unplanned Return to Theatre (Rate per 1,000 bed days) <0.45 >=0.56 >=0.45 and <0.56 <0.45 Safety Hospital Acquired Medication Complications (Rate per 1,000 bed days) <0.75 >=1.00 >=0.75 and <1.00 <0.75

Smoking During Pregnancy. At any time (%): Equity  Aboriginal women Decrease from previous year Increase on previous year No change Decrease from previous year Equity  Non-aboriginal women Decrease from previous year Increase on previous year No change Decrease from previous year Effectiveness Pregnant Women Quitting Smoking - By second half of pregnancy (%) 4% increase on previous year <1% increase on previous year ≥1% and <4% increase on previous year 4% increase on previous year 1.4 Population Health Human Immunodeficiency Virus (HIV) Testing - Within publicly-funded HIV and sexual health services: Variance (%) Individual - See Data Supplement <98 Target >=98 and <100 >=100 Effectiveness Hepatitis C Antiviral Treatment Initiation – Direct acting - by LHD residents: Variance (%) Individual - See Data Supplement <98 Target >=98 and <100 >=100 Strategy 2: Provide World-Class Clinical Care Where Patient Safety is First 2.1 Safety Fall-related Injuries in Hospital – Resulting in fracture or intracranial injury – Rate (per 1,000 bed days) <0.12 0.13 >=0.15 0.16 >=0.12 0.13 and <0.15 0.16 <0.12 0.13 Safety 3rd or 4th Degree Perineal Lacerations During Delivery (Rate per 1,000 bed days) <0.28 0.38 >=0.39 0.53 >=0.28 0.38 and <0.39 0.53 <0.28 0.38 Safety Hospital Acquired Venous Thromboembolism (Rate per 1,000 bed days) <0.21 0.32 >=0.30 0.46 >=0.21 0.32 and <0.30 0.46 <0.21 0.32 Safety Hospital Acquired Pressure Injuries (Rate per 1,000 bed days) <0.27 0.24 >=0.44 0.39 >=0.27 0.24 and <0.44 0.39 <0.27 0.24 Safety Healthcare Associated Infections (per 1,000 bed days) <2.64 3.92 >=2.99 4.45 >=2.64 3.92 and <2.99 4.45 <2.64 3.92 Safety Surgical Complications Requiring Unplanned Return to Theatre (Rate per 1,000 bed days) <0.45 0.80 >=0.56 1.01 >=0.45 0.80 and <0.56 1.01 <0.45 0.80 Safety Hospital Acquired Medication Complications (Rate per 1,000 bed days) <0.75 0.97 >=1.00 1.28 >=0.75 0.97 and <1.00 1.28 <0.750.97

Smoking During Pregnancy. At any time (%): Equity  Aboriginal women Decrease from previous year Increase on previous year No change Decrease from previous year Equity  Non-aboriginal women Decrease from previous year Increase on previous year No change Decrease from previous year Effectiveness Pregnant Women Quitting Smoking - By second half of pregnancy (%) 4% increase on previous year <1% increase on previous year ≥1% and <4% increase on previous year 4% increase on previous year 1.4 Population Health Human Immunodeficiency Virus (HIV) Testing - Within publicly-funded HIV and sexual health services: Variance (%) Individual - See Data Supplement <98 Target >=98 and <100 >=100 Effectiveness Hepatitis C Antiviral Treatment Initiation – Direct acting - by LHD residents: Variance (%) Individual - See Data Supplement <98 Target >=98 and <100 >=100 Strategy 2: Provide World-Class Clinical Care Where Patient Safety is First 2.1 Safety Fall-related Injuries in Hospital – Resulting in fracture or intracranial injury – Rate (per 1,000 bed days) <0.12 0.15 >=0.19 >=0.15 >=0.12 and <0.19 <0.15 <0.12 Safety 3rd or 4th Degree Perineal Lacerations During Delivery (Rate per 1,000 bed days) <0.28 0.32 >=0.39 0.44 >=0.28 0.32 and <0.39 0.44 <0.28 0.32 Safety Hospital Acquired Venous Thromboembolism (Rate per 1,000 bed days) <0.21 0.22 >=0.30 0.33 >=0.21 0.22 and <0.30 0.33 <0.21 0.22 Safety Hospital Acquired Pressure Injuries (Rate per 1,000 bed days) <0.27 0.26 >=0.44 0.42 >=0.27 0.26 and <0.44 0.42 <0.27 0.26 Safety Healthcare Associated Infections (per 1,000 bed days) <2.64 2.69 >=2.99 3.05 >=2.64 2.69 and <2.99 3.05 <2.64 2.69 Safety Surgical Complications Requiring Unplanned Return to Theatre (Rate per 1,000 bed days) <0.45 0.40 >=0.56 0.51 >=0.45 0.40 and <0.56 0.51 <0.45 0.40 Safety Hospital Acquired Medication Complications (Rate per 1,000 bed days) <0.75 1.07 >=1.00 1.42 >=0.75 1.07 and <1.00 1.42 <0.751.07

Smoking During Pregnancy. At any time (%): Equity  Aboriginal women Decrease from previous year Increase on previous year No change Decrease from previous year Equity  Non-aboriginal women Decrease from previous year Increase on previous year No change Decrease from previous year Effectiveness Pregnant Women Quitting Smoking - By second half of pregnancy (%) 4% increase on previous year <1% increase on previous year ≥1% and <4% increase on previous year 4% increase on previous year 1.4 Population Health Human Immunodeficiency Virus (HIV) Testing - Within publicly-funded HIV and sexual health services: Variance (%) Individual - See Data Supplement <98 Target >=98 and <100 >=100 Effectiveness Hepatitis C Antiviral Treatment Initiation – Direct acting - by LHD residents: Variance (%) Individual - See Data Supplement <98 Target >=98 and <100 >=100 Strategy 2: Provide World-Class Clinical Care Where Patient Safety is First 2.1 Safety Fall-related Injuries in Hospital – Resulting in fracture or intracranial injury – Rate (per 1,000 bed days) <0.12 0.17 >=0.15 0.21 >=0.12 0.17 and <0.15 0.21 <0.12 0.17 Safety 3rd or 4th Degree Perineal Lacerations During Delivery (Rate per 1,000 bed days) <0.28 0.37 >=0.39 0.52 >=0.28 0.37 and <0.39 0.52 <0.28 0.37 Safety Hospital Acquired Venous Thromboembolism (Rate per 1,000 bed days) <0.21 0.14 >=0.30 0.20 >=0.21 0.14 and <0.30 0.20 <0.21 0.14 Safety Hospital Acquired Pressure Injuries (Rate per 1,000 bed days) <0.27 0.20 >=0.44 0.34 >=0.27 0.20 and <0.44 0.34 <0.27 0.20 Safety Healthcare Associated Infections (per 1,000 bed days) <2.64 2.45 >=2.99 2.77 >=2.64 2.45 and <2.99 2.77 <2.64 2.45 Safety Surgical Complications Requiring Unplanned Return to Theatre (Rate per 1,000 bed days) <0.45 0.17 >=0.56 0.22 >=0.45 0.17 and <0.56 0.22 <0.45 0.17 Safety Hospital Acquired Medication Complications (Rate per 1,000 bed days) <0.75 0.66 >=1.00 0.87 >=0.75 0.66 and <1.00 0.87 <0.750.66

Smoking During Pregnancy. At any time (%): Equity  Aboriginal women Decrease from previous year Increase on previous year No change Decrease from previous year Equity  Non-aboriginal women Decrease from previous year Increase on previous year No change Decrease from previous year Effectiveness Pregnant Women Quitting Smoking - By second half of pregnancy (%) 4% increase on previous year <1% increase on previous year ≥1% and <4% increase on previous year 4% increase on previous year 1.4 Population Health Human Immunodeficiency Virus (HIV) Testing - Within publicly-funded HIV and sexual health services: Variance (%) Individual - See Data Supplement <98 Target >=98 and <100 >=100 Effectiveness Hepatitis C Antiviral Treatment Initiation – Direct acting - by LHD residents: Variance (%) Individual - See Data Supplement <98 Target >=98 and <100 >=100 Strategy 2: Provide World-Class Clinical Care Where Patient Safety is First 2.1 Safety Fall-related Injuries in Hospital – Resulting in fracture or intracranial injury – Rate (per 1,000 bed days) <0.12 0.11 >=0.15 0.14 >=0.12 0.11 and <0.15 0.14 <0.12 0.11 Safety 3rd or 4th Degree Perineal Lacerations During Delivery (Rate per 1,000 bed days) <0.28 0.50 >=0.39 0.69 >=0.28 0.50 and <0.39 0.69 <0.28 0.50 Safety Hospital Acquired Venous Thromboembolism (Rate per 1,000 bed days) <0.21 0.25 >=0.30 0.36 >=0.21 0.25 and <0.30 0.36 <0.21 0.25 Safety Hospital Acquired Pressure Injuries (Rate per 1,000 bed days) <0.27 0.26 >=0.44 0.43 >=0.27 0.26 and <0.44 0.43 <0.27 0.26 Safety Healthcare Associated Infections (per 1,000 bed days) <2.64 3.34 >=2.99 3.78 >=2.64 3.34 and <2.99 3.78 <2.64 3.34 Safety Surgical Complications Requiring Unplanned Return to Theatre (Rate per 1,000 bed days) <0.45 0.61 >=0.56 0.77 >=0.45 0.61 and <0.56 0.77 <0.45 0.61 Safety Hospital Acquired Medication Complications (Rate per 1,000 bed days) <0.75 0.90 >=1.00 1.19 >=0.75 0.90 and <1.00 1.19 <0.750.90

Smoking During Pregnancy. At any time (%): Equity  Aboriginal women Decrease from previous year Increase on previous year No change Decrease from previous year Equity  Non-aboriginal women Decrease from previous year Increase on previous year No change Decrease from previous year Effectiveness Pregnant Women Quitting Smoking - By second half of pregnancy (%) 4% increase on previous year <1% increase on previous year ≥1% and <4% increase on previous year 4% increase on previous year 1.4 Population Health Human Immunodeficiency Virus (HIV) Testing - Within publicly-funded HIV and sexual health services: Variance (%) Individual - See Data Supplement <98 Target >=98 and <100 >=100 Effectiveness Hepatitis C Antiviral Treatment Initiation – Direct acting - by LHD residents: Variance (%) Individual - See Data Supplement <98 Target >=98 and <100 >=100 Strategy 2: Provide World-Class Clinical Care Where Patient Safety is First 2.1 Safety Fall-related Injuries in Hospital – Resulting in fracture or intracranial injury – Rate (per 1,000 bed days) <0.12 0.16 >=0.15 0.19 >=0.12 0.16 and <0.15 0.19 <0.12 0.16 Safety 3rd or 4th Degree Perineal Lacerations During Delivery (Rate per 1,000 bed days) <0.28 0.32 >=0.39 0.44 >=0.28 0.32 and <0.39 0.44 <0.28 0.32 Safety Hospital Acquired Venous Thromboembolism (Rate per 1,000 bed days) <0.21 0.26 >=0.30 0.38 >=0.21 0.26 and <0.30 0.38 <0.21 0.26 Safety Hospital Acquired Pressure Injuries (Rate per 1,000 bed days) <0.27 >=0.44 >=0.27 and <0.44 <0.27 Safety Healthcare Associated Infections (per 1,000 bed days) <2.64 3.75 >=2.99 4.25 >=2.64 3.75 and <2.99 4.25 <2.64 3.75 Safety Surgical Complications Requiring Unplanned Return to Theatre (Rate per 1,000 bed days) <0.45 0.61 >=0.56 0.77 >=0.45 0.61 and <0.56 0.77 <0.45 0.61 Safety Hospital Acquired Medication Complications (Rate per 1,000 bed days) <0.75 0.90 >=1.00 1.20 >=0.75 0.90 and <1.00 1.20 <0.750.90

Smoking During Pregnancy. At any time (%): Equity  Aboriginal women Decrease from previous year Increase on previous year No change Decrease from previous year Equity  Non-aboriginal women Decrease from previous year Increase on previous year No change Decrease from previous year Effectiveness Pregnant Women Quitting Smoking - By second half of pregnancy (%) 4% increase on previous year <1% increase on previous year ≥1% and <4% increase on previous year 4% increase on previous year 1.4 Population Health Human Immunodeficiency Virus (HIV) Testing - Within publicly-funded HIV and sexual health services: Variance (%) Individual - See Data Supplement <98 Target >=98 and <100 >=100 Effectiveness Hepatitis C Antiviral Treatment Initiation – Direct acting - by LHD residents: Variance (%) Individual - See Data Supplement <98 Target >=98 and <100 >=100 Strategy 2: Provide World-Class Clinical Care Where Patient Safety is First 2.1 Safety Fall-related Injuries in Hospital – Resulting in fracture or intracranial injury – Rate (per 1,000 bed days) <0.12 0.13 >=0.15 0.16 >=0.12 0.13 and <0.15 0.16 <0.12 0.13 Safety 3rd or 4th Degree Perineal Lacerations During Delivery (Rate per 1,000 bed days) <0.28 0.34 >=0.39 0.46 >=0.28 0.34 and <0.39 0.46 <0.28 0.34 Safety Hospital Acquired Venous Thromboembolism (Rate per 1,000 bed days) <0.21 0.18 >=0.30 0.27 >=0.21 0.18 and <0.30 0.27 <0.21 0.18 Safety Hospital Acquired Pressure Injuries (Rate per 1,000 bed days) <0.27 0.21 >=0.44 0.34 >=0.27 0.21 and <0.44 0.34 <0.27 0.21 Safety Healthcare Associated Infections (per 1,000 bed days) <2.64 2.88 >=2.99 3.27 >=2.64 2.88 and <2.99 3.27 <2.64 2.88 Safety Surgical Complications Requiring Unplanned Return to Theatre (Rate per 1,000 bed days) <0.45 0.44 >=0.56 >=0.45 0.44 and <0.56 <0.45 0.44 Safety Hospital Acquired Medication Complications (Rate per 1,000 bed days) <0.75 0.76 >=1.00 1.01 >=0.75 0.76 and <1.00 1.01 <0.750.76